3 completed, 1 active not recruiting. 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Childhood T Acute Lymphoblastic Leukemia: new trials by email Literature Review of Childhood T Acute Lymphoblastic Leukemia trials Research Report on Childhood T Acute Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Bortezomib, Cyclophosphamide, Cytarabine - Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 847 | 2014-10-04 | 2026-10-21 |
| Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Dexamethasone, Laboratory Biomarker Analysis, Methotrexate - Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia | Phase 1 | Completed | National Cancer Institute (NCI) | 13 | 2011-09-01 | 2015-07-10 |
| Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Asparaginase, Biospecimen Collection, Bone Marrow Biopsy - Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia | Phase 3 | Completed | Children's Oncology Group | 218 | 2008-01-15 | 2024-07-15 |
| Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia Cognitive Assessment, Diffusion Tensor Imaging, Laboratory Biomarker Analysis - Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia | Completed | Children's Oncology Group | 233 | 2007-01-01 | 2017-07-21 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia, Biphenotypic, Acute (1) · Lymphoma, T-Cell (1) · Neurotoxicity Syndromes (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Leukemia (3) · Leukemia, Lymphoid (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Chemically-Induced Disorders (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Nervous System Diseases (1) · Poisoning (1)
Calcium Dobesilate (3) · Dexamethasone (3) · Methotrexate (3) · Vincristine (3) · auricularum (3) · dexamethasone 21-phosphate (3) · dexamethasone acetate (3) · merphos (3) · pegaspargase (3) · Cyclophosphamide (2) · Cytarabine (2) · Daunorubicin (2) · Etoposide (2) · Hydrocortisone (2) · Leucovorin (2)
Children's Oncology Group (2) · National Cancer Institute (NCI) (2)
Canada (4) · United States (4) · Australia (3) · New Zealand (3)
David T Teachey (1) · Joanne M Hilden (1) · Naomi Winick (1) · Susan Rheingold (1)
PMID 32414848, PMID 35271306, PMID 36603187, PMID 38457359
U10CA098543 (3), U10CA180886 (2), U01CA097452 (1)